	US 7,449,484 B2
	Compounds
Jerry L. Adams, King of Prussia, Pa. (US); and Deborah L. Bryan, King of Prussia, Pa. (US)
Assigned to SmithKline Beecham Corporation, Philadelphia, Pa. (US)
Filed on Mar. 23, 2006, as Appl. No. 11/388,058.
Application 11/388058 is a continuation of application No. 10/432092, filed on May 20, 2003, abandoned.
Claims priority of provisional application 60/249963, filed on Nov. 20, 2000.
Prior Publication US 2006/0166988 A1, Jul. 27, 2006
Int. Cl. A61K 31/4439 (2006.01); C07D 401/04 (2006.01)

U.S. Cl. 514—341 [546/274.1]

6 Claims

1. A compound selected from:

2-tert-Butyl-4-naphthalen-2-yl-5-pyridin-4-yl-imidazole;

2-tert-Butyl-4-(6-Ethoxynaphthalen-2-yl)-5-pyridin-4-yl-imidazole;

4-(2-tert-Butyl-5-(6-methoxy-naphthalen-2-yl)-3H-imidazol-4-yl)-pyridine;

2-tert-Butyl-4-Inden-2-yl-5-pyridin-4-yl-1H-imidazole;

4-[2-tert-Butyl-5-(6-methoxy-naphthalen-2-yl)-1-methyl-1H-imidazol-4-yl]-pyridine;

or a pharmaceutically acceptable salts thereof.